Covid-19 patent disputes highlight safe harbour uncertainties for research tool innovators

Covid-19 patent disputes highlight safe harbour uncertainties for research tool innovators

Allele Therapeutics’ suits against Pfizer and Regeneron could have big implications for the extent to which platforms can monetise IP

Unlock unlimited access to all IAM content